Familial hypercholesterolemia is an autosomal codominant disorder associated with markedly elevated plasma concentration of LDL-cholesterol and increased cardiovascular risk. Homozygous patients have rapid development of atherosclerosis with death from cardiovascular disease even in childhood. Life-long recurrent apheresis to reduce plasma LDL-cholesterol is considered the gold standard for treatment. Liver transplantation can be curative for this condition, but is usually only considered after the development of cardiovascular disease. We report a 5.5-yr-old child initially misdiagnosed with heterozygous familial hypercholesterolemia and treated by low-fat diet only. In view of persistent hypercholesterolemia and development of xanthomatosis, new molecular studies indicated the presence of two different mutations in the LDL receptor gene, with one being a deletion of two exons not identifiable with standard sequencing analysis. Recurrent plasma apheresis in combination with statins lowered, but did not normalize plasma LDL-cholesterol levels. It caused progressive reduction of the size of xanthomas and prevented the development of vascular complications. After two yr, liver transplantation normalized LDL-cholesterol levels and completely resolved the skin lesions. Preemptive liver transplantation is a definitive cure of familial homozygous hypercholesterolemia and might be more effective if performed before development of vascular complications.

Preemptive liver transplantation in a child with familial hypercholesterolemia / Maiorana, A; Nobili, V; CALANDRA BUONAURA, Sebastiano; Francalanci, P; Bernabei, S; El Hachem, M; Monti, L; Gennari, F; Torre, G; de Ville de Goyet, J; Bartuli, A.. - In: PEDIATRIC TRANSPLANTATION. - ISSN 1397-3142. - STAMPA. - 15 (2):(2010), pp. e25-e29. [10.1111/j.1399-3046.2010.01383.x]

Preemptive liver transplantation in a child with familial hypercholesterolemia

CALANDRA BUONAURA, Sebastiano;
2010-01-01

Abstract

Familial hypercholesterolemia is an autosomal codominant disorder associated with markedly elevated plasma concentration of LDL-cholesterol and increased cardiovascular risk. Homozygous patients have rapid development of atherosclerosis with death from cardiovascular disease even in childhood. Life-long recurrent apheresis to reduce plasma LDL-cholesterol is considered the gold standard for treatment. Liver transplantation can be curative for this condition, but is usually only considered after the development of cardiovascular disease. We report a 5.5-yr-old child initially misdiagnosed with heterozygous familial hypercholesterolemia and treated by low-fat diet only. In view of persistent hypercholesterolemia and development of xanthomatosis, new molecular studies indicated the presence of two different mutations in the LDL receptor gene, with one being a deletion of two exons not identifiable with standard sequencing analysis. Recurrent plasma apheresis in combination with statins lowered, but did not normalize plasma LDL-cholesterol levels. It caused progressive reduction of the size of xanthomas and prevented the development of vascular complications. After two yr, liver transplantation normalized LDL-cholesterol levels and completely resolved the skin lesions. Preemptive liver transplantation is a definitive cure of familial homozygous hypercholesterolemia and might be more effective if performed before development of vascular complications.
15 (2)
e25
e29
Preemptive liver transplantation in a child with familial hypercholesterolemia / Maiorana, A; Nobili, V; CALANDRA BUONAURA, Sebastiano; Francalanci, P; Bernabei, S; El Hachem, M; Monti, L; Gennari, F; Torre, G; de Ville de Goyet, J; Bartuli, A.. - In: PEDIATRIC TRANSPLANTATION. - ISSN 1397-3142. - STAMPA. - 15 (2):(2010), pp. e25-e29. [10.1111/j.1399-3046.2010.01383.x]
Maiorana, A; Nobili, V; CALANDRA BUONAURA, Sebastiano; Francalanci, P; Bernabei, S; El Hachem, M; Monti, L; Gennari, F; Torre, G; de Ville de Goyet, J; Bartuli, A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/695094
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 44
social impact